NCT01074242View on ClinicalTrials.gov

ROTATEQ Reexamination Study (V260-037)

CompletedOBSERVATIONAL

Enrollment

3,798

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions

Gastroenteritis Rotavirus

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT01074242 - ROTATEQ Reexamination Study (V260-037) | Biotech Hunter | Biotech Hunter